Détail de l'auteur
Documents disponibles écrits par cet auteur (344)
Rapport
OEDT = EMCDDA ; L. VAN AERTS ; J. DE MORAIS ; M. EVANS-BROWN ; R. JORGE ; A. GALLEGOS ; R. CHRISTIE ; T. NÉFAU ; G. PLANCHUELO ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2022The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe. To support this, the report also provides a state-of-the-art review of the chemistry, pharmacology and toxico[...]Rapport
This paper offers a comparison of the drug strategies and plans adopted over the last five years by six intergovernmental organisations engaging 148 countries in four continents. It informs decision-makers, professionals and researchers working [...]Rapport
This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : Ce chapitre présente une vue d'ensemble des réponses au phénomène de la drogue en Europe et souligne, là où cela est possible, les tendances et les évolutions. Il examine dans un premier temps les mesures de prévention et se penche e[...]Rapport
OEDT = EMCDDA ; S. ELLIOTT ; S. BRANDT | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe), that was conducted by the Scientific Committee of the EMCDDA. Concer[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921), that was conducted by the Scientific Committee of the EMCDDA. Concern[...]Rapport
FRANÇAIS : L'Observatoire européen des drogues et toxicomanies présente les résultats de son étude sur l'évolution des risques concernant la 4-méthylthioamphétamine ou 4-MTA. Cette nouvelle drogue de synthèse est connue des autorités des Etats[...]Rapport
ENGLISH : This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The[...]Rapport
Rapport
OEDT = EMCDDA ; T. GROSHKOVA ; D. HEDRICH ; M. FERRI ; L. MONTANARI | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Today, in most European countries, residential treatment programmes form an important element of the range of treatment and rehabilitation options for drug users. The aim of this paper is to provide a Europe-wide overview of the history and avai[...]Rapport
OEDT = EMCDDA ; N. VAN HASSELT ; K. HUGHES ; G. BURKHART ; V. A. GYARMATHY | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012Drug and alcohol use in recreational settings are linked to a range of health and social problems. These include acute health problems, such as unconsciousness and unintentional injury, aggressive behaviour and violence, unsafe and unwanted sex,[...]Document multimédia
FRANÇAIS : Ce mini-guide donne un aperçu des aspects les plus importants à prendre en considération lors de la planification ou de la mise en œuvre de réponses sanitaires et sociales pour les personnes sans abri et qui consomment des drogues, e[...]Rapport
ENGLISH: Adolescence and young adulthood are life stages often associated with risk-taking and experimentation, which may include substance use. Schools and colleges are important settings in which to reach young people. This miniguide provides[...]Rapport
OEDT = EMCDDA ; G. HAY ; N. McKEGANEY ; L. WIESSING ; R. HARTNOLL ; P. Y. BELLO ; D. D'IPPOLITI ; A. DOMINGO-SALVANY ; M. FRISCHER ; L. KRAUS ; P. SMIT | Lisbon : OEDT / EMCDDA | EMCDDA Literature reviews, ISSN 1725-0579 | 1999Prevalence of problem drug use (PDU) is one of five key indicators used by the EMCDDA to provide more comparable, scientifically based estimates of the prevalence of more severe patterns of drug use that cannot be reliably measured by surveys. T[...]Congrès
L'objectif du séminaire est d'établir les bases nécessaires à une amélioration de la qualité, de la comparabilité et de la pertinence des estimations relatives à la prévalence de la toxicomanie en Europe. Les différentes sessions qui se sont sui[...]Rapport
OEDT = EMCDDA ; H. SUMNALL ; A. BROTHERHOOD | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2012In order to help drug users become full members of society following treatment, measures are needed that address the issues of housing, education, vocational training and employment as part of their recovery. This report considers existing inter[...]Document multimédia
OEDT = EMCDDA | 2010The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent statistical data relating to the drugs situation in Europe. Statistics are organised by category. In addition to the statistical tables and graphs,[...]Document multimédia
OEDT = EMCDDA | 2011The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent statistical data relating to the drugs situation in Europe. Statistics are organised by category. In addition to the statistical tables and graphs,[...]Rapport
ENGLISH : The aim of this report is to provide a descriptive and comparative review of the national drug strategies, action plans and coordination mechanisms adopted in the European Union, largely since the end of the 90s. In addressing this s[...]Rapport
Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the EU Early Warning System. The aim of this report is to strengthen situational awareness of synthetic cannabinoids [...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2017A higher prevalence of communicable diseases among people in prison compared with the general public is recognised as a public health issue as well as a major concern for the people affected, as the majority of incarcerated people return to thei[...]Rapport
OEDT = EMCDDA ; European Centre for Disease Prevention and Control | Lisbon : OEDT / EMCDDA | Joint publications | 2018Compared with the general public, people in prisons have a higher prevalence of infection with blood-borne viruses (BBVs) such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). This is recognised as a ma[...]Rapport
Use of the internet has changed drug dealing over the past decade. While there is a growing understanding of the role of darknet drug markets, little is known about how drug dealing works on public online services such as social media. This stud[...]Rapport
Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between [...]